The selective inhibition of CDK1 by small-molecule inhibitors, purvalanol or roscovitine, causes the suppression of the apoptosis protein BIRC5 (survivin), which is essential for the survival of MYC-driven tumor cells [178]. Here, MYC is linked to neoplasm.